• The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
• /
• v.37 no.1
• /
• pp.107-112
• /
• 2024

Objectives : This case report aims to demonstrate the effectiveness of incisional needle therapy in treating facial scars resulting from autoimmune disorder. Methods : A single case of a 29-year-old female patient with facial scars due to systemic sclerosis was treated with incisional needle therapy. The treatment was applied over 14 sessions from February to September 2023. The efficacy of the treatment was evaluated using clinical photographs and the Physician's Global Assessment(PGA). Results : The treatment significantly improved scar appearance and reduced blood vessel visibility. The PGA scores, with an average of 2.66, indicating moderate improvement. Conclusions : Incisional needle therapy demonstrated potential as an effective treatment for scars caused by autoimmune disorders, due to minimal side effects and non-interference with ongoing treatments. It offers a promising alternative to conventional treatments, suggesting a need for further research for wider applications.

• The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
• /
• v.37 no.2
• /
• pp.95-103
• /
• 2024

Objectives : This study aims to evaluate the effectiveness of incisional needle therapy, a type of Korean medicine treatment, on atrophic scars caused by herpes zoster and varicella. Methods : The patients with atrophic scars resulting from herpes zoster and varicella were treated with incisional needle therapy and the effectiveness of the treatment was evaluated with Physician's Global Assessment (PGA) and The Stony Brook Scar Evaluation Score (SBSES). Results : After treatment, all patients demonstrated improvements in PGA and SBSES. The PGA score improved to 3.73±0.40, with SBSES changing from 1.60±0.60 to 4.80±0.80. Conclusions : We suggest that incisional needle therapy demonstrates effectiveness in treating scars resulting from herpes zoster and varicella, indicating its potential as a viable therapeutic option for individuals affected by these conditions.

• Journal of Yeungnam Medical Science
• /
• v.16 no.2
• /
• pp.369-375
• /
• 1999

Chordoma is a slow-growing malignant neoplasm arising from the remnants of the primitive notochord. It accounts for 1 to 4% of all malignant bone tumors. It occurs exclusively along the spinal axis. Authors experienced four cases of chordoma occurred in the sacrococcygeal region. There were two male and two female patients, with a mean age of 63.5 years(range, 57~75 years). Tissue was obtained by wide excision in two patients, by incisional biopsy in one patient and by needle biopsy in the other. Adjuvant radiation therapy was performed on all the patients after their biopsy. The mean diameter of the tumors was 7.6cm(range, 5.5 to 13.0cm). Grossly, tumor was multiobulated, soft and myxoid gelatinous mass. Microscopically, the tumor showed lobulated feature divided by fibrous septa within it. There were physaliphorous cells with vacuolated bubbly cytoplasm. And small uniform, round, and non-vacuolated tumor cells were also present. On immunohistochemical stain, all the cases were immunoreactive for cytokeratin, epithelial membrane antigen(EMA) and vimentin, respectively. One of the 4 cases was positive for S-100 protein. All the cases were negative for CEA.